Form D · Biotechnology

SARcode Bioscience Inc.

Brisbane, CA · CIK 0001386215

Offering snapshot reported Jul 18, 2011 · SEC filing

Reported sold
$43.6M
Offering amount: $43.6M
Investors reported
9
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 15, 2011
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 18, 2011Initial$43,579,049No comparison9SEC filing
Dec 23, 2009Amendment$29,000,000$2,000,000vs Nov 12, 20097SEC filing
Nov 12, 2009Amendment$27,000,000No comparison7SEC filing
Jan 4, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-163031

Source: Form D, filed Jul 18, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Robert Alexander Director
John Burnier Executive, Promoter
Todd A Creech Executive
Emmett Cunningham Director
Thomas Gadek Director
Dennis Henner Director
Dan Janney Director
Garheng Kong Director
Mary Newman Executive
Quinton Oswald Director, Executive
Charles Semba Executive
Valerie Smith Executive
Martin Vogelbaum Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1000 Marina Parkway Suite 250
Brisbane, CA, 94005